Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Nature Reviews. Neurology
|
April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Annals of Neurology
|
October 27, 2011
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?
Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Travel Medicine and Infectious Disease
|
April 21, 2016
Health problems and behavioural risks in travellers to the tropics - A commentary
Benjamin T Schleenvoigt, Annett Zahlten, Micha Loebermann, et al.
Nature Reviews. Neurology
|
March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosis
Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 11, 2020
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study
Alexander Winkelmann, Christoph Metze, Silvius Frimmel, et al.
Travel Medicine and Infectious Disease
|
November 3, 2016
Does medical education predispose to risk behaviour during travel?
Benjamin T Schleenvoigt, Annett Zahlten, Micha Loebermann, et al.
Infection
|
October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults
Micha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Plos One
|
May 3, 2011
Confocal laser scanning microscopy for detection of Schistosoma mansoni eggs in the gut of mice
Martha Charlotte Holtfreter, Oliver Stachs, Maria Reichard, et al.
Nature Reviews. Neurology
|
January 25, 2012
Vaccination against infection in patients with multiple sclerosis
Micha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults
Micha Loebermann, Herwig Kollaritsch, Tom Ziegler, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Nature Reviews. Neurology
|
April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Annals of Neurology
|
October 27, 2011
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?
Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Travel Medicine and Infectious Disease
|
April 21, 2016
Health problems and behavioural risks in travellers to the tropics - A commentary
Benjamin T Schleenvoigt, Annett Zahlten, Micha Loebermann, et al.
Nature Reviews. Neurology
|
March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosis
Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 11, 2020
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study
Alexander Winkelmann, Christoph Metze, Silvius Frimmel, et al.
Travel Medicine and Infectious Disease
|
November 3, 2016
Does medical education predispose to risk behaviour during travel?
Benjamin T Schleenvoigt, Annett Zahlten, Micha Loebermann, et al.
Infection
|
October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults
Micha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Plos One
|
May 3, 2011
Confocal laser scanning microscopy for detection of Schistosoma mansoni eggs in the gut of mice
Martha Charlotte Holtfreter, Oliver Stachs, Maria Reichard, et al.
Nature Reviews. Neurology
|
January 25, 2012
Vaccination against infection in patients with multiple sclerosis
Micha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults
Micha Loebermann, Herwig Kollaritsch, Tom Ziegler, et al.
Page
of 4